# Doxazosin

NDC: 71610-831
Generic name: Doxazosin
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170831

FDA application: ANDA208719

## Active ingredients

- DOXAZOSIN MESYLATE: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-831"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-831
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=187bc51b-7a3a-5910-e063-6294a90aa888